A FormBlends network publication
Semaglutide Hub

Semaglutide titration planner

Turn a first-dose date and the maintenance dose your prescriber chose into a dated plan that follows the Ozempic, Wegovy, Wegovy tablet, Rybelsus or Ozempic tablet label escalation, hold any step longer, and export every date to your calendar. Never pre-fills a dose.

By FormBlends editorial teamAssumptions checked September 4, 2026Runs in your browser; nothing is sent to a server

Inputs

Each product has its own label schedule. Compounded semaglutide has no label; use the schedule your prescriber wrote.

Left blank on purpose. The label lists more than one maintenance dose; only your prescriber picks one.

weeks

So the plan has an end date. Maintenance continues as prescribed.

Label rule: Weeks 1 to 4 at 0.25 mg, 5 to 8 at 0.5 mg, 9 to 12 at 1 mg, 13 to 16 at 1.7 mg, then maintenance at 2.4 mg (recommended) or 1.7 mg. In adults, 7.2 mg is allowed after at least 4 weeks tolerating 2.4 mg. If a step is not tolerated, the label says to consider delaying escalation for 4 weeks.

Plan

Choose the maintenance dose your prescriber wrote and the dated plan appears here, with a calendar file.

Formulashown in full, nothing hidden
phase k length     = label minimum doses at step k (or your longer hold)
phase k start      = phase k-1 end + interval          (interval = 7 days weekly, 1 day tablets)
phase k end        = phase k start + (doses - 1) x interval
maintenance start  = end of the last escalation phase + interval
total mg           = sum over phases of (dose x doses)

Dates are computed on calendar days in UTC, so a clock change never moves a dose. Holds can only lengthen a step; the tool refuses anything shorter than the label minimum.

Assumptions, checked September 4, 2026

  • Wegovy injection: 0.25, 0.5, 1 and 1.7 mg for 4 weeks each, then 2.4 mg (recommended) or 1.7 mg; 7.2 mg in adults after at least 4 weeks tolerating 2.4 mg. Wegovy label revised 6/2026.
  • Ozempic injection: 0.25 mg for 4 weeks, then 0.5 mg; 1 mg and 2 mg each after at least 4 weeks at the previous dose and only if more glycemic control is needed. Ozempic label revised 1/2025.
  • Wegovy tablets: 1.5, 4 and 9 mg for 30 days each, then 25 mg. Rybelsus: 3 mg for 30 days, then 7 mg, then 14 mg if needed. Ozempic tablets: 1.5 mg for 30 days, then 4 mg, then 9 mg if needed.
  • Missed doses are not applied here; use the missed-dose helper. Compounded semaglutide is not FDA approved and has no label schedule; the planner only does calendar arithmetic for a schedule your prescriber wrote.

This calculator is an arithmetic aid for medication a licensed prescriber has already prescribed. It does not recommend a dose. Confirm any result with your prescriber or pharmacist before use.

Sources

  1. Wegovy (semaglutide) injection and tablets prescribing information, revised 6/2026, DailyMed set id ee06186f-2aa3-4990-a760-757579d8f77b
  2. Ozempic (semaglutide) injection prescribing information, revised 1/2025, NDA 209637, Drugs@FDA
  3. Rybelsus and Ozempic (semaglutide) tablets prescribing information, revised 1/2026, DailyMed set id 27f15fac-7d98-4114-a2ec-92494a91da98

Read before you use it

Guides for this calculator

Semaglutide titration planner: Ozempic, Wegovy and tablet schedules by date

How the planner turns the label escalation schedules for Ozempic, Wegovy, Wegovy tablets, Rybelsus and Ozempic tablets into dated steps, what it refuses to do, and which decisions stay with your prescriber.

Updated September 4, 2026

Educational, not medical advice. Read the medical disclaimer.